Assessment of perfusion, function, and myocardial metabolism after infarction with a combination of low-dose dobutamine tetrofosmin gated SPECT perfusion scintigraphy and BMIPP SPECT imaging

Journal of Nuclear Cardiology

Volumn 7, Issue 1, 2000, Pages 29-36

  Everaert, Hendrik ^a   Vanhove, Christian ^a   Franken, Philippe R ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

BMIPP; Gated SPECT perfusion scintigraphy; Low dose dobutamine

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; DOBUTAMINE; TETROFOSMIN;

ADULT; AGED; ALGORITHM; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HEART VENTRICLE HYPERTROPHY; HUMAN; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0034002947     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1067/mnc.2000.103135     Document Type: Article

References (24)

1. Bonow R. Identification of viable myocardium. Circulation 1996;94:2674-80.
2. Opie LH, Hesse B. Radionuclide tracers in the evaluation of resting myocardial ischaemia and viability. Eur J Nucl Med 1997;24: 1183-93.
3. Pierard LA, Landsheere CM, Berthe C, et al. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy, comparison with positron emission tomography. J Am Coll Cardiol 1990;15:1021-31.
4. Smart SC, Sawada S, Ryan Th, et al. Low dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993;88:405-15.
5. Hawman PC, Haines EJ. The Cardiofocal collimator: a variable-focus collimator for cardiac SPET. Phys Med Biol 1994;39:439-50.
6. Everaert H, Vanhove C, Hamill JJ, et al. Cardiofocal collimators for gated single-photon emission tomographic myocardial perfusion imaging. Eur J Nucl Med 1998;25:3-7.
7. Franken PR, DeGeeter F, Dendale P, et al. Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and inotropic reserve. J Nucl Med 1994;35:1758-65.
8. Franken PR, Dendale P, DeGeeter F, et al. Prediction of functional outcome after myocardial infarction using BMIPP and sestamibi scintigraphy. J Nucl Med 1996;37:718-22.
9. Everaert H, Vanhove C, Schoors D, et al. Quantitative assessment of regional dysfunction from gated single-photon emission tomography myocardial perfusion studies: a non-segmental approach. Nucl Med Commun 1999;20:335-43.
10. Germano G, Kiat H, Kavanagh P, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995;36:2138-47.
11. 123I radioiodination of 15 (p-l-phenyl)-9-methyl pentadecanoic acid, a potential myocardial tracer. Eur J Nucl Med 1987;13:159-60.
12. DeGeeter F, Franken PR, Defrise M, et al. Optimal colimator choice for sequential iodine-123 and technetium-99m imaging. Eur J Nucl Med 1996;23:768-74.
13. Chua T, Kiat H, Germano G, et al. Gated technetium-99m sestamibi for simultaneous assessment of myocardial perfusion postexercise regional ventricular function and myocardial viability. Correlation with echocardiography and rest thallium-201 scintigraphy. J Am Coll Cardiol 1994;23:1107-14.
14. Tischler MD, Niggel JB, Battle RW, Fairnbank JT, Brown KA. Validation of global and segmental left ventricular contractile function using gated planar technetium-99m sestamibi myocardial perfusion imaging. J Am Coll Cardiol 1994;23:141-5.
15. 99mTc-MIBI emission tomography and by magnetic resonance imaging. Eur J Nucl Med 1996;23:909-16.
16. Stollfuss JC, Haas F, Matsunari I, et al. Regional myocardial wall thickening and global ejection fraction in patients with low angiographic left ventricular ejection fraction assessed by visual and quantitative resting ECG-gated 99mTc-tetrofosmin single-photon emission tomography and magnetic resonance imaging. Eur J Nucl Med 1998;25:522-30.
17. Gunning MG, Anagnostopoulos C, Davies G, Forbat SA, Ell PJ, Underwood R. Gated technetium-99m-tetrofosmin SPECT and cine MRI to assess the ventricular contraction. J Nucl Med 1997;38:39-442.
18. Everaert H, Vanhove C, Franken RR. Effects of low-dose dobutamine on left ventricular function in normal subjects as assessed by gated single-photon emission tomography myocardial perfusion studies. Submitted to Eur J Nucl Med.
19. Tamaki N, Kawamoto M, Yonekura Y, et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infraction: assessment with emission tomography using an iodinated branched fatty acid analogue. J Nucl Med 1992;33:659-67.
20. 99mTc-MIBI and 123I-beta-methyl iodophenyl pentadecanoic acid. Eur J Nucl Med 1994;21:283-91.
21. 201T1 single-photon emission computed tomography. Circulation 1995; 91:2748-52.
22. Panza JA, Dilsizian V, Laurienzo JM, Curici RV, Katsiyiannis PT. Relation between thallium uptake and contractile response to dobutamine. Implications regarding myocardial viability in patients with chronic coronary artery disease and left ventricular dysfunction. Circulation 1995;91:990-8.
23. Melon PG, de Landsheere CM, Degueldre C, Peters JL, Kulbertus HE, Pierard LA. Relation between contractile reserve and positron emission tomographic patterns of perfusion and glucose utilization in chronic ischemic left ventricular dysfunction: implications for identification of myocardial viability. J Am Coll Cardiol 1997;30:1651-9.
24. Kitsiou AN, Srinivasan G, Quyyumi AA, Summers RM, Bacharach SL, Dilsizian V. Stress-induced reversible and mild-to-moderate irreversible thallium defects: are they equally accurate for predicting functional recovery of regional left ventricular function after revascularization? Circulation 1998;98:501-8.